The medical device innovation lifecycle
Innovation is the cornerstone of progress in health technologies. It’s the spark that ignites new solutions to unmet clinical needs, improving patient outcomes, and making healthcare systems work better for everyone.
Yet, the path from idea to market is rarely straightforward. The medical device landscape is constantly shifting, shaped by rapidly evolving technologies, regulations and market needs. For first-time innovators, the journey can feel like navigating an unfamiliar city without a map.
That’s because medical device innovation is a living, interconnected process that is rarely linear. The development lifecycle encompasses a range of activities, often happening in parallel, with each stage influencing the others. As a product advances through the lifecycle, it encounters new requirements, and usually, the need to reconsider and refine earlier work.
Bringing a medical device to life is also rarely a solo act. It’s a team sport, one that thrives on the shared expertise of scientists, clinicians, patients and users, regulatory and quality specialists, market access strategists, and marketing and sales professionals. Each brings a different, yet vital perspective. Success comes from weaving those insights together into a single, coherent vision.
Navigating this terrain calls for more than just technical skill. It requires systematic processes, frameworks and methodologies tailored to the industry’s unique challenges and constraints.
The number one reason why medical device companies fail pre-revenue: they run out of money. Developing a well-thought-out strategy and product plan removes ambiguity from the journey and increases the chance of successful commercialisation. And it all begins with establishing a robust business plan.
Early research
The medical device innovation process begins with robust early-stage research to establish a strong evidence-based business case. This is essential to building credibility with stakeholders, including investors and partners. Although it’s the most critical task in medical device innovation, it’s also often the most neglected (probably because much of the work is boring).
Early-stage research identifies unmet clinical needs and assesses the feasibility of potential solutions, laying the foundation for product-market fit. It involves gathering evidence on technical, clinical, economic and regulatory aspects, ensuring proposed products effectively address real-world problems.
Early research reveals the competitive landscape, highlights potential risks, and uncovers manufacturing and market access challenges. Best practices leverage systematic, comprehensive evidence gathering that follows industry or international standards and prioritises reputable data sources.
Ideation
Every medical device starts as an idea.
Ideas for new or improved medical devices or other health technology products can come from almost any source. Patients, relatives, carers and medical professionals have unique insights into unmet needs in the care continuum. Scientists and engineers know of emerging technologies that could be applied to health innovations.
Ideation is a structured process that focuses on identifying unmet needs and brainstorming solutions. The goal is to generate a pool of ideas, each of which must be evaluated for its potential and prioritised for further development.
Ideation begins with problem identification, which requires understanding a disease, its clinical characteristics, and the current medical landscape (known as the State-of-the-Art (SotA)). Existing solutions are identified, including predicate devices, devices in development, and alternative technologies. The initial problem recognition triggers brainstorming sessions, where ideas and concepts for new or improved medical products are developed to address existing medical problems. Innovation frameworks can support structured ideation, helping create and evaluate ideas systematically.
The objective is not just to find easier, cheaper, or more effective ways to address medical challenges but to do so in a way that benefits us collectively. An initial evaluation narrows down the ideas to those with the highest potential. The best are prioritised for the next lifecycle stage: conception.
Conception
Conception, or concept development, involves selecting ideas to expand into detailed, evidence-based product concepts. This stage focuses on defining the product’s intended purpose, features, and functionality at a high level.
The primary output of conception is a draft intended purpose statement, with multiple versions often created for exploration during the research and feasibility phase. Clear, detailed concepts form the foundation for subsequent development activities.
Research and feasibility
The research and feasibility phases refine the draft intended purpose statement and define user requirements (or user needs) and design specifications (or design inputs) for the final product. If multiple concepts were developed earlier, this phase narrows them.
Technology landscaping is a strategic approach to systematically collecting, analysing, and interpreting data on current and emerging technologies within the sector. It is the most important (and cost-effective) tool for medical device innovators. By thoroughly analysing interconnected landscapes, innovators can make well-informed strategic decisions and maintain competitiveness in the fast-evolving medical device market.
Research and feasibility studies aim to assess the product’s technical, clinical, IP, regulatory, market, and economic feasibility. Landscaping is predominantly a desk research activity. However, there may be outstanding questions that can only be answered through technical research (bench studies, in silico studies, or prototyping) and user research. The outputs from early research activities include:
- Feasibility determination (technical, clinical, and financial).
- User requirements for design and development (D&D).
- Design Inputs outlining technical and functional specifications.
- IP management strategy and plan.
- Market access strategy (regulatory strategy, business model development, including financing and pricing strategies/models and reimbursement strategy).
- A final business case and plan for the product.
When research and feasibility studies are complete, a formal review determines whether the concept proceeds to design and development (D&D), where formal design controls are applied. If multiple concepts are viable, they can be prioritised, and a technology roadmap can be created for future product development.
Risk management
No medical intervention is without risk.
Every health technology, including medical devices, has the capacity to cause harm. Risk is defined as the probability of a harm occurring, multiplied by the severity of that harm. Identifying, quantifying and mitigating risk is a central tenet of medical device regulation.
Risk management, guided by ISO 14971, is a systematic process for identifying, evaluating, and mitigating risk. It usually starts during early-stage research activities and continues throughout the medical device lifecycle.
Design and Development (D&D)
Design and Development (D&D) is a resource-intensive stage of the medical device lifecycle. It transitions the project from creative exploration to formal, regulated processes. Thorough early-stage research helps to ensure a smoother D&D process, although iterative design changes may still be necessary.
D&D activities are governed by Quality Management System (QMS) standards (e.g., ISO 13485:2016 and Quality System Regulation (QSR)) and design control requirements. Design controls are a systematic process mandated by regulatory authorities to ensure that medical devices are designed to meet user needs, intended purposes, and regulatory requirements. They encompass planning, documenting, reviewing, and verifying each design development stage, from establishing user requirements to design transfer to manufacture.
The culmination of D&D is a manufacturable product supported by technical documentation containing all the evidence of the benefits and risks of the device. These documents support regulatory submissions.
Manufacture
Manufacturing is central to the medical device lifecycle, transforming design specifications into tangible products while meeting quality, regulatory, and cost requirements.
A manufacturing process is a series of steps and operations used to transform raw materials into finished products. It involves using equipment, reagents, tools, labour, and technology to produce items to specified standards and requirements. Manufacturing processes are formalised during the design transfer stage of design controls, which translates design outputs into products. Early consideration of manufacturing processes, materials and verification and validation activities helps ensure the final product’s manufacturability, scalability, and cost-effectiveness.
As with every other stage of medical device innovation, processes and all the inputs to manufacture (equipment, materials, labour and technology) are subject to regulation. Quality assurance (QA) ensures that products are designed, manufactured, and distributed to meet stringent safety, efficacy, and reliability standards.
Market access
Market access ensures medical devices are available to those needing them by addressing regulatory, clinical, economic, marketing, sales and service challenges. It includes:
- Regulatory Submissions: Submitting technical documentation substantiating the clinical and safety benefits and risks to regulatory authorities. Obtaining certifications to market the device legally is a prerequisite for market access, but it does not guarantee adoption.
- Health Technology Assessment (HTA): HTA is the structured process of evaluating a medical device’s value to inform financing and adoption decisions. HTA assesses clinical and safety benefits and risks, but also considers the economic, social, organisational and ethical implications of a medical device product. Payers and healthcare providers use this information to guide the adoption and financing of medical devices.
- Pricing: Developing strategies that balance affordability with profitability while engaging payers and customers to secure payment for medical device products.
- Financing: Exploring different payment mechanisms, including public/private reimbursement, capital expenditure purchases, leasing models, or out-of-pocket purchases.
- Marketing: Building awareness and demand through branding, thought leadership, and outreach to healthcare professionals and patients. It may also involve building awareness with key stakeholders such as payers and the government.
- Sales: Equipping commercial teams with training, tools, and systems to engage customers effectively and drive revenue.
- Service: Providing user training and support, preventative and corrective maintenance and value-added services.
A comprehensive approach to market access integrates regulatory strategy with payer and user engagement to promote adoption. Continuously evaluating and expanding reach into new markets, patient populations, and indications to sustain long-term growth also helps market success.
Post-market activities
Once a medical device product is placed on the market, a range of activities ensues to ensure its continued efficacy, safety and compliance. Marketing, sales and service continue as long as a product is available on the market. Regulatory compliance also continues throughout the whole lifecycle and remains in place even after a product is withdrawn from the market.
Post-market surveillance is a specific post-market activity that is a regulatory requirement with two components:
- Vigilance: Monitoring for adverse events, customer complaints and quality issues.
- Post-market studies: Proactive clinical and user studies in real-world settings.
Post-market surveillance aims to address any issues that arise promptly and to continuously improve a product based on its performance in the market.
Putting it all together
The lifecycle of a medical device is not a series of isolated steps but a continuous, interconnected journey. Decisions made in early research influence regulatory and market access strategies, which in turn shape manufacturing, commercialisation potential, and long-term post-market responsibilities. Recognising these links is essential for developing products that are not only compliant but also commercially viable and sustainable.
To build a deeper understanding, we encourage you to explore other sections of our Knowledge Hub. From development and evidence generation to regulation, reimbursement, distribution, and partnerships, each topic connects back to the broader lifecycle - helping you see how every decision contributes to the success of your product.
